Haema 2013; 4(1):1-12
by Maria Papaioannou1, Eleni Gatsa2
1Hematology Unit, 1st Department of Internal Medicine of Medical School, Thessaloniki, AUTH,
2Outpatient Haematology Clinic, General Hospital of Trikala, Greece
Author: admin
Hodgkin lymphoma in specific subgroups of patients
Haema 2012; 3(3):321-327
by Katerina Pyrovolaki, Maria Psillaki, Helen A. Papadakis
Hematology Clinic, University Hospital of Heraklion, University School of Medicine Crete, Creece
Continue reading “Hodgkin lymphoma in specific subgroups of patients”
Unusual clinical manifestations and complications of Hodgkin lymphoma
Haema 2012; 3(3):307-320
by Argiris S. Symeonidis
Hematology Division, Dept of Int.Medicine, University Hospital of Patras, Greece
Continue reading “Unusual clinical manifestations and complications of Hodgkin lymphoma”
Nodular lymphocyte predominant Hodgkin lymphoma
Haema 2012; 3(3):298-306
by Flora N. Kontopidou, Theoni Kanellopoulou
Second Department of Internal Medicinec, National and Kapodistrian University of Athens, Ippokration General Hospital, Athens, Greece
Continue reading “Nodular lymphocyte predominant Hodgkin lymphoma”
Long-term complications of treatment for Hodgkin lymphoma
Haema 2012; 3(3): 285-297
by Paraskevi Roussou1, Stamatis Karakatsanis2
1Associate Professor of Internal Medicine-Hematology, Hematology Unit, 3rd University Department of Internal Medicine, General Hospital of Chest Diseases “Sotiria”,
2Hematology resident, Hematology and Lymphomas’ Clinic and Bone Marrow Transplantation Unit, General Hospital of Athens “Evaggelismos”
Continue reading “Long-term complications of treatment for Hodgkin lymphoma”
The role of 18FDG PET/CT in the evaluation of Hodgkin lymphoma
Haema 2012; 3(3): 275-284
by Phivi Rondogianni1 and Ioannis Apostolidis2
1Department of Nuclear Medicine-PET/CT,
2Department of Haematology and Lymphomas and Bone Marrow Transplantation, “Evangelismos” General Hospital, Athens, Greece
Continue reading “The role of 18FDG PET/CT in the evaluation of Hodgkin lymphoma”
Allogeneic hematopoietic stem cell (allo-HSCT) transplantation in Hodgkin lymphoma
Haema 2012; 3(3): 266-274
by Panayotis Kaloyannidis1, Panagiotis Tsirigotis2, Ioanna Sakellari1
1Department of Haematology and Bone Marrow Transplantation, Papanikolaou General Hospital, Thessaloniki,
2Second Department of Internal Medicine, Propaedeutic, University of Athens, University General Hospital “Attikon”, Greece
Targeted therapy in Hodgkin lymphoma – Clinical aspects
Haema 2012; 3(3): 260-265
by Ioannis Kotsianidis, Εmmanouil Spanoudakis, Konstantinos Tsatalas
Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece
Continue reading “Targeted therapy in Hodgkin lymphoma – Clinical aspects”
Biologic Basis of Novel Therapeutic Strategies in Hodgkin Lymphoma
Haema 2012; 3(3): 250-259
by Elias Drakos1, George Rassidakis2
1Lecturer of Pathology, Medical School, University of Crete, Greece,
2Assistant Professor of Pathology, School of Medicine, National and Kapodistrian University of Athens, Greece, Adjunct Assistant Professor of Hematopathology The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Continue reading “Biologic Basis of Novel Therapeutic Strategies in Hodgkin Lymphoma”
Treatment of relapsed/refractory Hodgkin lymphoma
Haema 2012; 3(3): 239-249
by Maria K. Angelopoulou, Pagona Flevaris, Theodoros P. Vassilakopoulos
National and Kapodistrian University of Athens, Department of Hematology and Bone Marrow Transplantation, “Laikon” General Hospital, Athens, Greece
Continue reading “Treatment of relapsed/refractory Hodgkin lymphoma”
Principles of radiation therapy in Hodgkin lymphoma
Haema 2012; 3(3): 231-238
by Ioannis Georgakopoulos1, Evangelia Peponi2, Miltiades Trichas1
1Radiation Oncology Center, IASO Hospital, 2Radiation Oncology Department, Ioannina University Hospital
Continue reading “Principles of radiation therapy in Hodgkin lymphoma”
Hodgkin Lymphoma: First line treatment and prognostic factors
Haema 2012; 3(3): 212-230
by Theodoros P. Vassilakopoulos, Georgios Boutsikas, Andreas Sarris, Maria K. Angelopoulou
Department of Haematology, National and Kapodistrian University of Athens, Laikon General Hospital, Goudi, Athens, Greece
Continue reading “Hodgkin Lymphoma: First line treatment and prognostic factors”
Hodgkin Lymphoma: clinical and laboratory findings and staging procedures
Haema 2012; 3(3): 203-211
by Gerasimos A. Pangalis1,2, Maria Moschogiannis1, Xanthi Giakoumi1, Pantelis τsirkinidis1,3, Sotirios Sachanas1
1Department of Haematology, Athens Medical Center, Psychikon Branch,
2Department of Haematology, National and Kapodistrian University of Athens,
3Department of Haematology, 401 General Army Hospital, Athens, Greece
Continue reading “Hodgkin Lymphoma: clinical and laboratory findings and staging procedures”
Biology of Hodgkin Lymphoma
Haema 2012; 3(3): 190-202
by Sotirios G. Papageorgiou, Vasiliki Pappa, Ioannis Dervenoulas
Second Department of Internal Medicine, Propaedeutic, Hematology Unit, University of Athens, University General Hospital “Attikon”
Hodgkin lymphoma: histological features and classification
Haema 2012; 3(3): 185-189
by Penelope Korkolopoulou, Georgia Levidou, Efstratios Patsouris
First Department of Pathology, Laiko Hospital, University of Athens, Medical School, Athens, Greece
Continue reading “Hodgkin lymphoma: histological features and classification”